Citation: P. Wohlfart et al., POSSIBLE PHYSIOLOGICAL-ROLE OF ANGIOTENSI N II-(SUBTYPE AT(2))-RECEPTORS IN ISCHEMIC RAT HEARTS AND BOVINE AORTIC ENDOTHELIAL-CELLS, Nieren- und Hochdruckkrankheiten, 24(6), 1995, pp. 311-314
Authors:
GOHLKE P
LINZ W
SCHOLKENS BA
KUWER I
BARTENBACH S
SCHNELL A
UNGER T
Citation: P. Gohlke et al., CHRONIC ANGIOTENSIN AT RECEPTOR BLOCKADE IMPROVES CARDIAC-FUNCTION AND METABOLISM IN SHRSP, Hypertension, 26(3), 1995, pp. 563-563
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CONTRIBUTION OF KININS TO THE CARDIOVASCULAR ACTIONS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, Pharmacological reviews, 47(1), 1995, pp. 25-49
Authors:
STAHL W
BREIPOHL G
KUHLMANN L
STEINSTRASSER A
GERHARDS HJ
SCHOLKENS BA
Citation: W. Stahl et al., TC-99M-LABELED HOE-140 - A POTENTIAL BRADYKININ B-2 RECEPTOR IMAGING AGENT, Journal of medicinal chemistry, 38(15), 1995, pp. 2799-2801
Authors:
SCHOLZ W
ALBUS U
COUNILLON L
GOGELEIN H
LANG HJ
LINZ W
WEICHERT A
SCHOLKENS BA
Citation: W. Scholz et al., PROTECTIVE EFFECTS OF HOE642, A SELECTIVE SODIUM-HYDROGEN EXCHANGE SUBTYPE-1 INHIBITOR, ON CARDIAC ISCHEMIA AND REPERFUSION, Cardiovascular Research, 29(2), 1995, pp. 260-268
Citation: Kj. Wirth et al., KININ RECEPTOR ANTAGONISTS - UNIQUE PROBES IN BASIC AND CLINICAL RESEARCH, Canadian journal of physiology and pharmacology, 73(7), 1995, pp. 797-804
Citation: W. Linz et al., EXPERIMENTAL-EVIDENCE FOR EFFECTS OF RAMIPRIL ON CARDIAC AND VASCULARHYPERTROPHY BEYOND BLOOD-PRESSURE REDUCTION, Archives des maladies du coeur et des vaisseaux, 88, 1995, pp. 31-34
Authors:
GOHLKE P
LINZ W
SCHOLKENS BA
WIEMER G
MARTORANA P
VANEVEN P
UNGER T
Citation: P. Gohlke et al., EFFECT OF CHRONIC HIGH-DOSE AND LOW-DOSE ACE-INHIBITOR TREATMENT ON CARDIAC AND VASCULAR HYPERTROPHY AND VASCULAR FUNCTION IN SPONTANEOUSLYHYPERTENSIVE RATS, Experimental nephrology, 2(2), 1994, pp. 93-93
Citation: Kj. Wirth et al., THE BRADYKININ-B-2 RECEPTOR ANTAGONIST WIN-64338 INHIBITS THE EFFECT OF DES-ARG(9)-BRADYKININ IN ENDOTHELIAL-CELLS, European journal of pharmacology. Molecular pharmacology section, 288(1), 1994, pp. 1-2
Citation: X. Chen et al., RAMIPRIL (R) REVERSES OXIDIZED LDL-INDUCED INHIBITION OF VASODILATIONAND ATTENUATES ATHEROGENESIS IN CHOLESTEROL-FED RABBITS, The FASEB journal, 8(5), 1994, pp. 10000662-10000662
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CARDIOPROTECTIVE EFFECTS BY RAMIPRIL AFTER ISCHEMIA AND REPERFUSION IN EXPERIMENTAL STUDIES, Zeitschrift fur Kardiologie, 83, 1994, pp. 53-56
Authors:
WIEMER G
FINK E
KORTH P
WOHLFART P
SCHOLKENS BA
LINZ W
Citation: G. Wiemer et al., BLOCKADE OF ANG-II (SUBTYPE AT(1)) RECEPTORS INDUCES KININ AND PROSTACYCLIN RELEASE FROM ISOLATED-PERFUSED RAT HEARTS, Hypertension, 24(3), 1994, pp. 396-396
Authors:
GOHLKE P
LINZ W
SCHOLKENS BA
KUWER I
BARTENBACH S
SCHNELL A
UNGER T
Citation: P. Gohlke et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IMPROVES CARDIAC-FUNCTION - ROLE OF BRADYKININ, Hypertension, 23(4), 1994, pp. 411-418
Authors:
SACK S
MOHRI M
SCHWARZ ER
ARRAS M
SCHAPER J
BALLAGIPORDANY G
SCHOLZ W
LANG HJ
SCHOLKENS BA
SCHAPER W
Citation: S. Sack et al., EFFECTS OF A NEW NA+ H+ ANTIPORTER INHIBITOR ON POSTISCHEMIC REPERFUSION IN PIG-HEART/, Journal of cardiovascular pharmacology, 23(1), 1994, pp. 72-78
Citation: W. Linz et al., CARDIOPROTECTIVE ACTIONS OF BRADYKININ IN MYOCARDIAL-ISCHEMIA AND LEFT-VENTRICULAR HYPERTROPHY, Brazilian journal of medical and biological research, 27(8), 1994, pp. 1949-1954
Authors:
HROPOT M
GROTSCH H
KLAUS E
LANGER KH
LINZ W
WIEMER G
SCHOLKENS BA
Citation: M. Hropot et al., RAMIPRIL PREVENTS THE DETRIMENTAL SEQUELS OF CHRONIC NO SYNTHASE INHIBITION IN RATS - HYPERTENSION, CARDIAC-HYPERTROPHY AND RENAL-INSUFFICIENCY, Naunyn-Schmiedeberg's archives of pharmacology, 350(6), 1994, pp. 646-652
Authors:
WIEMER G
FINK E
LINZ W
HROPOT M
SCHOLKENS BA
WOHLFART P
Citation: G. Wiemer et al., FUROSEMIDE ENHANCES THE RELEASE OF ENDOTHELIAL KININS, NITRIC-OXIDE AND PROSTACYCLIN, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1611-1615
Citation: G. Wiemer et al., ENHANCEMENT OF CYTOSOLIC CALCIUM, PROSTACYCLIN AND NITRIC-OXIDE BY BRADYKININ AND THE ACE-INHIBITOR RAMIPRILAT IN PORCINE BRAIN CAPILLARY ENDOTHELIAL-CELLS, Brain research, 638(1-2), 1994, pp. 261-266
Authors:
LINZ W
HEITSCH H
HENNING R
JUNG W
KLEEMANN HW
NICKEL WU
RUPPERT D
URBACH H
WAGNER A
SCHOLKENS BA
Citation: W. Linz et al., EFFECTS OF THE RENIN INHIBITOR CLOHEXYL-3,4-DIHYDROXY-6(2-PYRIDYL)-HEXANE-2-AMIDE ACETATE IN ANESTHETIZED RHESUS-MONKEYS, Arzneimittel-Forschung, 44-2(7), 1994, pp. 815-820
Citation: W. Linz et al., CONTRIBUTION OF BRADYKININ TO THE CARDIOVASCULAR EFFECTS OF RAMIPRIL, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000001-190000008
Authors:
SCHOLZ W
ALBUS U
LANG HJ
LINZ W
MARTORANA PA
ENGLERT HC
SCHOLKENS BA
Citation: W. Scholz et al., HOE-694, A NEW NA+ H+ EXCHANGE INHIBITOR AND ITS EFFECTS IN CARDIAC ISCHEMIA/, British Journal of Pharmacology, 109(2), 1993, pp. 562-568